Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delayed introduction of sirolimus with tacrolimus elimination in de novo renal transplant recipients
2009-016762-87Phase 4Active
- Sponsor
- Policlinico di Milano
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sirolimus in kidney allograft rejection (2 arms), sponsored by Policlinico di Milano. Primary endpoint: graft survival at 1 year. Started Nov 2009; status: active.
02
Drugs
sirolimus
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on 2009-016762-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016762-87.